A detailed history of Gfs Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gfs Advisors, LLC holds 47,553 shares of JNJ stock, worth $6.95 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
47,553
Previous 47,330 0.47%
Holding current value
$6.95 Million
Previous $7.42 Million 1.4%
% of portfolio
1.25%
Previous 1.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$155.22 - $162.74 $34,614 - $36,291
223 Added 0.47%
47,553 $7.52 Million
Q4 2023

Jan 24, 2024

BUY
$145.6 - $158.88 $543,088 - $592,622
3,730 Added 8.56%
47,330 $7.42 Million
Q3 2023

Oct 19, 2023

BUY
$155.75 - $174.48 $2.71 Million - $3.04 Million
17,431 Added 66.61%
43,600 $6.79 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $37,044 - $39,866
240 Added 0.93%
26,169 $4.33 Million
Q1 2023

Apr 27, 2023

BUY
$151.05 - $180.26 $197,271 - $235,419
1,306 Added 5.3%
25,929 $4.02 Million
Q4 2022

Jan 26, 2023

BUY
$160.2 - $179.79 $17,622 - $19,776
110 Added 0.45%
24,623 $0
Q3 2022

Oct 13, 2022

SELL
$161.33 - $179.52 $69,371 - $77,193
-430 Reduced 1.72%
24,513 $4 Million
Q2 2022

Jul 19, 2022

SELL
$168.19 - $186.01 $503,560 - $556,913
-2,994 Reduced 10.72%
24,943 $4.43 Million
Q1 2022

Apr 21, 2022

SELL
$158.14 - $179.59 $2.97 Million - $3.38 Million
-18,800 Reduced 40.23%
27,937 $4.95 Million
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $5.74 Million - $6.37 Million
36,820 Added 371.28%
46,737 $8 Million
Q3 2021

Nov 03, 2021

SELL
$161.5 - $179.47 $152,617 - $169,599
-945 Reduced 8.7%
9,917 $1.6 Million
Q2 2021

Jul 26, 2021

BUY
$159.48 - $171.07 $39,870 - $42,767
250 Added 2.36%
10,862 $1.79 Million
Q1 2021

May 03, 2021

BUY
$153.07 - $170.48 $278,587 - $310,273
1,820 Added 20.7%
10,612 $1.74 Million
Q2 2020

Jul 29, 2020

SELL
$128.81 - $155.51 $51,524 - $62,204
-400 Reduced 4.35%
8,792 $1.24 Million
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $1.37 Million - $1.89 Million
-12,300 Reduced 57.23%
9,192 $1.21 Million
Q4 2019

Jan 17, 2020

SELL
$127.5 - $146.44 $1.95 Million - $2.24 Million
-15,279 Reduced 41.55%
21,492 $3.14 Million
Q3 2019

Oct 31, 2019

BUY
$126.95 - $142.14 $154,879 - $173,410
1,220 Added 3.43%
36,771 $4.76 Million
Q2 2019

Aug 01, 2019

BUY
$131.15 - $144.24 $26,230 - $28,848
200 Added 0.57%
35,551 $4.95 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $15,086 - $16,774
-120 Reduced 0.34%
35,351 $4.94 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $393,088 - $473,088
-3,200 Reduced 8.27%
35,471 $4.58 Million
Q3 2018

Nov 27, 2018

SELL
$121.58 - $142.88 $5.83 Million - $6.85 Million
-47,950 Reduced 55.36%
38,671 $5.34 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $215,196 - $252,897
1,770 Added 2.09%
86,621 $12 Million
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $268,650 - $296,460
2,250 Added 2.72%
84,851 $10.3 Million
Q1 2018

May 09, 2018

BUY
$125.1 - $148.14 $1.39 Million - $1.65 Million
11,125 Added 15.56%
82,601 $10.6 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $59,049 - $64,629
-450 Reduced 0.63%
71,476 $9.99 Million
Q3 2017

Nov 07, 2017

SELL
$129.47 - $135.38 $213,625 - $223,377
-1,650 Reduced 2.24%
71,926 $9.35 Million
Q2 2017

Aug 07, 2017

BUY
N/A
73,576
73,576 $9.73 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gfs Advisors, LLC Portfolio

Follow Gfs Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfs Advisors, LLC with notifications on news.